Hologic Receives FDA 510(k) Clearance to Market SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin)

Patients in Clinical Studies Report 100% Satisfaction Rate MARLBOROUGH, Mass., Sept. 27, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted an expa... Devices, Dermatology, FDA, Product Launch Hologic, SculpSure, double chin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news